Workflow
Pet medications
icon
Search documents
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of PetMed Express, Inc. (NASDAQ: PETS) and Encourages Investors with Substantial Losses to Contact the Firm
Prnewswireยท 2025-11-28 20:03
Company Overview - PetMed Express, Inc. is an online pet pharmacy founded in 1996, offering a wide range of medications, supplements, food, and other pet health products [3] Allegations and Stock Performance - On June 10, 2025, PetMed announced a delay in releasing its fourth-quarter and full-year 2025 financial results, leading to a stock drop of $0.47, or 11.22%, closing at $3.72 on June 11, 2025 [4] - On July 1, 2025, PetMed stated it would not file its fiscal-year 2025 Annual Report on time due to an internal review of revenue recognition, resulting in a stock decline of $0.05 per share, or 1.51%, finishing at $3.27 [5] - On November 12, 2025, PetMed reported it could not timely submit its third-quarter 2025 Form 10-Q due to an Audit Committee investigation, causing a significant stock price drop of $0.94 per share, or 32.41%, closing at $1.96 on November 13, 2025 [6] Legal Investigation - Edelson Lechtzin LLP is investigating potential violations of federal securities laws involving PetMed Express, stemming from allegations of providing misleading business information to the investing public [1]